RecruitingNot Applicable

The Role of Laryngopharyngeal Reflux in IPF

United States60 participantsStarted 2018-08-01

Plain-language summary

The primary objective of this study is to show that the Supraglottic Index (SGI) is an easily-collected index that accurately identifies the presence and severity of laryngopharyngeal reflux (LPF) in idiopathic pulmonary fibrosis (IPF).

Who can participate

Age range40 Years – 95 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosis of IPF * Age 40-95 * Able to read, speak, and understand English * If subjects are currently taking medication for reflux or GERD, they much be on a stable does for at least 4 weeks prior to consent. Exclusion Criteria: * Patients who do not meet all inclusion criteria * Pregnant females

What they're measuring

The supraglottic index (SGI) quantifies laryngopharyngeal reflux (LPF) and is associated with severity of pulmonary fibrosis.

Timeframe: 6 months

Trial details

NCT IDNCT03418350

SponsorNational Jewish Health

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-12

Contact for this trial

Matthew Koslow, MPH

303-398-1996 ILDresearch@njhealth.org

View on ClinicalTrials.gov More IPF trials